DE3479477D1 - A pharmaceutical composition for use in treating neurological disease or aging - Google Patents
A pharmaceutical composition for use in treating neurological disease or agingInfo
- Publication number
- DE3479477D1 DE3479477D1 DE8484303195T DE3479477T DE3479477D1 DE 3479477 D1 DE3479477 D1 DE 3479477D1 DE 8484303195 T DE8484303195 T DE 8484303195T DE 3479477 T DE3479477 T DE 3479477T DE 3479477 D1 DE3479477 D1 DE 3479477D1
- Authority
- DE
- Germany
- Prior art keywords
- aging
- pharmaceutical composition
- neurological disease
- choline
- treating neurological
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 208000012902 Nervous system disease Diseases 0.000 title abstract 2
- 208000025966 Neurological disease Diseases 0.000 title abstract 2
- 230000032683 aging Effects 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 abstract 3
- 229960001231 choline Drugs 0.000 abstract 3
- 239000000203 mixture Substances 0.000 abstract 2
- 239000002243 precursor Substances 0.000 abstract 2
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 abstract 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 abstract 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 abstract 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 abstract 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 abstract 1
- 239000004473 Threonine Substances 0.000 abstract 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 abstract 1
- 230000002411 adverse Effects 0.000 abstract 1
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000002708 enhancing effect Effects 0.000 abstract 1
- 239000002858 neurotransmitter agent Substances 0.000 abstract 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 abstract 1
- 230000002195 synergetic effect Effects 0.000 abstract 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
- A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US49520283A | 1983-05-16 | 1983-05-16 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE3479477D1 true DE3479477D1 (en) | 1989-09-28 |
Family
ID=23967687
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE8484303195T Expired DE3479477D1 (en) | 1983-05-16 | 1984-05-11 | A pharmaceutical composition for use in treating neurological disease or aging |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP0125900B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JPS60214734A (cg-RX-API-DMAC7.html) |
| AT (1) | ATE45672T1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA1228301A (cg-RX-API-DMAC7.html) |
| DE (1) | DE3479477D1 (cg-RX-API-DMAC7.html) |
| ES (1) | ES8602409A1 (cg-RX-API-DMAC7.html) |
| GR (1) | GR79973B (cg-RX-API-DMAC7.html) |
| IL (1) | IL71819A (cg-RX-API-DMAC7.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2657013B1 (fr) * | 1990-01-18 | 1992-05-15 | Medgenix Group Sa | Composition dietetique a base de polypeptides et acides amines. |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1114295A (en) * | 1977-11-02 | 1981-12-15 | John H. Growdon | Process and composition for treating disorders by administering choline or a compound that dissociates to choline |
| DE2967257D1 (en) * | 1978-04-24 | 1984-11-22 | Massachusetts Inst Technology | Composition for regulating dopamine or norepinephrine levels in neuronal synapses |
| DE2962429D1 (en) * | 1978-04-24 | 1982-05-19 | Massachusetts Inst Technology | A pharmaceutical composition comprising an amino acid for reducing blood serum prolactin levels |
| US4296119A (en) * | 1978-04-24 | 1981-10-20 | Massachusetts Institute Of Technology | Process and composition for reducing blood pressure in animals |
| JPS5566512A (en) * | 1978-11-15 | 1980-05-20 | Massachusetts Inst Technology | Method and composition for treating difficulties by administration of choline or choline dissociating compound |
| US4221784A (en) * | 1979-04-05 | 1980-09-09 | Massachusetts Institute Of Technology | Process and composition for treating disorders by administering lecithin |
| DE2915433A1 (de) * | 1979-04-17 | 1980-10-30 | Christensen Plantorgan Werk | Verwendung von physiologisch vertraeglichen methyldonatoren |
| US4397866A (en) * | 1979-05-07 | 1983-08-09 | Massachusetts Institute Of Technology | Process for increasing glycine levels in the brain and spinal cord |
-
1984
- 1984-05-11 AT AT84303195T patent/ATE45672T1/de not_active IP Right Cessation
- 1984-05-11 DE DE8484303195T patent/DE3479477D1/de not_active Expired
- 1984-05-11 EP EP84303195A patent/EP0125900B1/en not_active Expired
- 1984-05-13 IL IL71819A patent/IL71819A/xx not_active IP Right Cessation
- 1984-05-14 JP JP59094739A patent/JPS60214734A/ja active Granted
- 1984-05-15 ES ES532873A patent/ES8602409A1/es not_active Expired
- 1984-05-16 CA CA000454518A patent/CA1228301A/en not_active Expired
- 1984-05-16 GR GR74742A patent/GR79973B/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP0125900A1 (en) | 1984-11-21 |
| IL71819A0 (en) | 1984-09-30 |
| JPH0141124B2 (cg-RX-API-DMAC7.html) | 1989-09-04 |
| IL71819A (en) | 1987-12-31 |
| ES532873A0 (es) | 1985-12-16 |
| ES8602409A1 (es) | 1985-12-16 |
| EP0125900B1 (en) | 1989-08-23 |
| JPS60214734A (ja) | 1985-10-28 |
| GR79973B (cg-RX-API-DMAC7.html) | 1984-10-31 |
| ATE45672T1 (de) | 1989-09-15 |
| CA1228301A (en) | 1987-10-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU1943388A (en) | 3-indolepyruvic acid derivatives and pharmaceutical use thereof | |
| DE69132688D1 (de) | Methode zur behandlung und vorbeugung von typ-1 diabetis durch orale verabreichung von insulin | |
| DE68919358D1 (de) | Zusammensetzung zur behandlung der schizophrenie. | |
| GB2128088B (en) | Oral mopidamol preparations | |
| YU209288A (en) | Process for producing compound for treating, which contains azelastin for use in nose and/or eye | |
| SG115093G (en) | Therapeutic composition containing gamma-linolenicacid and an assimilable form of calcium | |
| DE69316013D1 (de) | Verwendung von phosphinate zur behandlung der osteoporose | |
| GR3002842T3 (en) | N-substituted 3-piperidine-or 3-pyridine-carboxylic acids and derivatives thereof | |
| IL83775A (en) | Amino acid esters and amides of fumaric acid and pharmaceutical compositions containing them for use in the treatment of psoriasis | |
| GR79973B (cg-RX-API-DMAC7.html) | ||
| DE3774291D1 (de) | Verwendung von oligopeptiden zur behandlung von cerebralen stoerungen. | |
| DE2966809D1 (en) | 3,4-diaza-bicyclo(4.1.0)hepten-2-ones-5, process for their preparation and therapeutical compositions containing them | |
| ES2038847T3 (es) | Proceso para la preparacion de una composicion farmacutica conteniendo zidovudine e inosiplex para el tratamiento del sida y sindromes afines. | |
| IL88726A0 (en) | Dihydrothienobenzodiazepinone derivatives,pharmaceutical compositions containing the same and processes for the preparation thereof | |
| KR880004810A (ko) | 소화성 궤양 치료제 | |
| AU1621888A (en) | Pharmaceutical compositions for the treatment of cerebral psycho-organic syndromes | |
| EP0144489A3 (en) | Cerebral and peripheral antihypoxidoticum | |
| DE3879489D1 (de) | Pharmazeutische kompositionen zum behandeln von adrenoleukodystrophie. | |
| DK0434989T3 (da) | Fremgangsmåde til forbedring af ventilationen under søvn og til behandling af søvnrelaterede ventilationsabnormaliteter | |
| HU210902A9 (en) | 3-substituted-2-oxindole derivatives as inhibitors of interleukin-1 biosynthesis | |
| DE3162674D1 (en) | A purified polypeptide, a process for its preparation, its use and pharmaceutical compositions containing it | |
| DE69220229D1 (de) | Somatotropin zur erhoehung der reproduktiven leistung in rinder | |
| EP0267402A3 (en) | Use of follicle regulatory protein for the production of a therapeutic agent for the treatment of neoplasm of gonadal origin | |
| EP0147194A3 (en) | Method and compositions for treating cerebral ischemia |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition | ||
| 8339 | Ceased/non-payment of the annual fee |